Lower Rates of Staphylococcus aureus Bloodstream Infection in Patients on Hemodialysis Receiving Trimethoprim-Sulfamethoxazole Melioidosis Prophylaxis

被引：4

作者：

Bryce, Aliya ^{[1
,2
]}

Davison, Sara ^{[1
]}

Currie, Bart J. ^{[1
,3
]}

Birrell, Johanna M. ^{[4
]}

Baird, Robert W. ^{[1
]}

Abeyaratne, Asanga ^{[3
,5
,6
,7
]}

Majoni, Sandawana William ^{[3
,5
,6
,7
]}

Brewster-O'Brien, Teana ^{[5
]}

Tong, Steven Y. C. ^{[8
,9
]}

机构：

[1] Royal Darwin Hosp, Dept Infect Dis, Darwin, NT, Australia

[2] Royal Melbourne Hosp, Dept Gen Med, 300 Grattan St, Melbourne, Vic 3052, Australia

[3] Charles Darwin Univ, Menzies Sch Hlth Res, Darwin, NT, Australia

[4] NT Hlth, Northern Terr Ctr Dis Control, Darwin, NT, Australia

[5] Royal Darwin Hosp, Dept Nephrol, Darwin, NT, Australia

[6] Flinders Univ S Australia, Darwin, NT, Australia

[7] Royal Darwin Hosp Campus, Northern Terr Med Program, Darwin, NT, Australia

[8] Royal Melbourne Hosp, Peter Doherty Inst Infect & Immun, Victorian Infect Dis Serv, Melbourne, Vic, Australia

[9] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Infect Dis, Melbourne, Vic, Australia

来源：

OPEN FORUM INFECTIOUS DISEASES | 2024年 / 11卷 / 08期

关键词：

antibiotic prophylaxis; bloodstream infection; hemodialysis; Staphylococcus aureus; trimethoprim-sulfamethoxazole; RISK; BACTEREMIA;

D O I：

10.1093/ofid/ofae431

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Hemodialysis is a risk factor for Staphylococcus aureus bloodstream infection (SAB). In this single-center study, SAB rates were 56% lower during the monsoonal wet season when patients on hemodialysis receive supervised melioidosis prophylaxis with trimethoprim-sulfamethoxazole. This intervention may reduce SAB rates in high-risk patients; however, further targeted studies are required. Graphical abstract https://tidbitapp.io/institutional-portal/open-forum-infectious-diseases/tidbits/lower-rates-of-staphylococcus-aureus-bloodstream-infection-in-patients-on-hemodialysis-receiving-trimethoprim-sulfamethoxazole-melioidosis-prophylaxis/update In the Northern Territory of Australia, patients on hemodialysis receive seasonal post-dialysis Trimethoprim-Sulfamethoxazole as melioidosis prophylaxis. This single-center study explored the effect of this intervention on rates of Staphylococcus Aureus bloodstream infections in this high risk group.

引用

页数：4

共 50 条

[21] Antimicrobial activity of daptomycin and selected comparators tested against bloodstream Staphylococcus aureus isolates from hemodialysis patients [J].

Sader, Helio S. ;

Fritsche, Thomas R. ;

Jones, Ronald N. .

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2009, 13 (02) :291-295

[22] Has the Time Come for Routine Trimethoprim-Sulfamethoxazole Prophylaxis in Patients Taking Biologic Therapies? [J].

Bodro, Marta ;

Paterson, David L. .

CLINICAL INFECTIOUS DISEASES, 2013, 56 (11) :1621-1628

[23] Use of desensitization for reintroducing trimethoprim-sulfamethoxazole in hypersensitive patients with HIV infection. [J].

Caumes, E .

ANNALES DE MEDECINE INTERNE, 1997, 148 (02) :172-176

[24] TRIMETHOPRIM-SULFAMETHOXAZOLE OR CLINDAMYCIN FOR TREATMENT OF COMMUNITY-ACQUIRED METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS SKIN AND SOFT TISSUE INFECTIONS [J].

Hyun, David Y. ;

Mason, Edward O. ;

Forbes, Andrea ;

Kaplan, Sheldon L. .

PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2009, 28 (01) :57-59

[25] Safety and efficacy evaluation of low-dose trimethoprim-sulfamethoxazole for prophylaxis of Pneumocystis pneumonia in HIV uninfected patients undergoing hemodialysis: a retrospective observational study [J].

Kanae Yamashita ;

Yoshimitsu Shimomura ;

Hiroaki Ikesue ;

Nobuyuki Muroi ;

Akihiro Yoshimoto ;

Tohru Hashida .

BMC Infectious Diseases, 21

[26] Safety and efficacy evaluation of low-dose trimethoprim-sulfamethoxazole for prophylaxis of Pneumocystis pneumonia in HIV uninfected patients undergoing hemodialysis: a retrospective observational study [J].

Yamashita, Kanae ;

Shimomura, Yoshimitsu ;

Ikesue, Hiroaki ;

Muroi, Nobuyuki ;

Yoshimoto, Akihiro ;

Hashida, Tohru .

BMC INFECTIOUS DISEASES, 2021, 21 (01)

[27] Osteomyelitis due to methicillin-resistant Staphylococcus aureus successfully treated by an oral combination of minocycline and trimethoprim-sulfamethoxazole [J].

Sato, Kojiro ;

Yazawa, Hiroaki ;

Ikuma, Daisuke ;

Maruyama, Takashi ;

Kajiyama, Hiroshi ;

Mimura, Toshihide .

SAGE OPEN MEDICAL CASE REPORTS, 2019, 7

[28] Integrative Analysis of Whole Genome Sequencing and Phenotypic Resistance Toward Prediction of Trimethoprim-Sulfamethoxazole Resistance in Staphylococcus aureus [J].

Nurjadi, Dennis ;

Zizmann, Elfi ;

Chanthalangsy, Quan ;

Heeg, Klaus ;

Boutin, Sebastien .

FRONTIERS IN MICROBIOLOGY, 2021, 11

[29] Patients at Risk of Complications of Staphylococcus aureus Bloodstream Infection [J].

del Rio, Ana ;

Cervera, Carlos ;

Moreno, Asuncion ;

Moreillon, Phillipe ;

Miro, Jose M. .

CLINICAL INFECTIOUS DISEASES, 2009, 48 :S246-S253

[30] Exebacase for patients with Staphylococcus aureus bloodstream infection and endocarditis [J].

Fowler, Vance G., Jr. ;

Das, Anita F. ;

Lipka-Diamond, Joy ;

Schuch, Raymond ;

Pomerantz, Roger ;

Jauregui-Peredo, Luis ;

Bressler, Adam ;

Evans, David ;

Moran, Gregory J. ;

Rupp, Mark E. ;

Wise, Robert ;

Corey, G. Ralph ;

Zervos, Marcus ;

Douglas, Pamela S. ;

Cassino, Cara .

JOURNAL OF CLINICAL INVESTIGATION, 2020, 130 (07) :3750-3760

← 1 2 3 4 5 →